Vaping lung damage (review)
- Authors: Titova O.N.1, Kulikov V.D.1, Sukhovskaya O.A.1,2
-
Affiliations:
- Academician I.P. Pavlov First St. Petersburg State Medical University
- St. Petersburg State Research Institute of Phthisiopulmonology
- Issue: Vol 14, No 3 (2023)
- Pages: 111-120
- Section: Reviews
- URL: https://journals.rcsi.science/pediatr/article/view/254589
- DOI: https://doi.org/10.17816/PED143111-120
- ID: 254589
Cite item
Abstract
The review presents data from meta-analyses and original studies on the study of the vapers disease — electronic cigarette or vaping product use-associated lung injury (EVALI) — a new nosological form in patients with acute and subacute respiratory diseases caused by the consumption of electronic nicotine delivery vehicles, or vaping. The number of users are growing in around the world, especially among young people. According to a 2022 meta-analysis, the global prevalence of vaping use was 23%, including 16% in women and 22% in men. Prevalence of electronic nicotine delivery systems among cigarette smokers reached 43%, while on different continents, except for Asia, during the life it was approximately the same: in America — 24%, Europe — 26%, Asia — 16%, Oceania — 25%. Vaping rates among children aged 15 to 17 are almost four times (21.3%) higher than those aged 12–14 (5.4%). Two-thirds (66.1%) of children aged 12 to 17 using electronic nicotine delivery devices were also smokers, while they started with vapes. Nicotine cartridges used by 89.3% of teen vapers aged 15 to 19 years. Vaping lung diseases have been reported since invention e-cigarettes, but the number of cases increased sharply at the end of September 2019, and by February In 2020, the number of hospitalized patients in the United States reached 2807, with 68 confirmed deaths. Most of the cases are male adolescents and men aged 13–34 years. The review discusses the etiology, clinical picture, imaging findings, pathological EVALI features. When examining patients with EVALI, computed tomography revealed images characteristic of acute lung injury and pneumonia, as well as those resembling non-fibrous hypersensitivity pneumonitis, acute eosinophilic pneumonia. The article discusses the main differences between these diseases and the computed tomography picture of COVID-19. Before EVALI, vaping was associated with a wide range of pulmonary manifestations, including lipoid pneumonia, acute respiratory distress syndrome and diffuse alveolar hemorrhage. Although the overall prevalence of EVALI has declined sharply compared to with a peak in September 2019, other chemicals may appear that cause various pulmonary diseases associated with vaping. EVALI is a new nosological form in patients with acute and subacute respiratory diseases caused by lung damage due to the use of electronic means delivery of nicotine. The appearance of radiographic images in EVALI is diverse: from bilateral opacities in the lungs to reveal centrilobular nodules resembling non-fibrous hypersensitivity pneumonitis. When interpreting acute lung injury in young people, the possibility of EVALI should be considered.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Olga N. Titova
Academician I.P. Pavlov First St. Petersburg State Medical University
Author for correspondence.
Email: titovaon@spb-gmu.ru
MD, PhD, Dr. Med. Sci., Professor, Director Research Institute of Pulmonology, Saint Petersburg Research Institute of Pulmonology
Russian Federation, Saint PetersburgValery D. Kulikov
Academician I.P. Pavlov First St. Petersburg State Medical University
Email: vdkulikov@mail.ru
MD, PhD, Leading Researcher of Research Institute of Pulmonology
Russian Federation, Saint PetersburgOlga A. Sukhovskaya
Academician I.P. Pavlov First St. Petersburg State Medical University; St. Petersburg State Research Institute of Phthisiopulmonology
Email: ktc01@mail.ru
Dr. Biol. Sci., Department Head of Research Institute of Pulmonology, Academician I.P. Pavlov First St. Petersburg State Medical University, Ministry of Health of the Russian Federation; Centre Head, Tobacco Cessation Assistance Advisory Telephone Center, Saint Petersburg State Research Institute of Phthisiopulmonology, Ministry of Health of the Russian Federation
Russian Federation, Saint Petersburg; Saint PetersburgReferences
- Breslav IS, Bryantseva LA, Voronov IB, et al editors. Fiziologiya dykhaniya. Saint Petersburg: Nauka, 1994. (In Russ.)
- Vyutrih EV, Svirido DA, Pozdnyakova TD. Osobennosti vedeniya patsientov s odyshkoi posle perenesennogo COVID-19. University therapeutic journal. 2022;4: 13–14. (In Russ.)
- Sukhovskaya OA. Coronavirus 2019-nCoV (short message). Medical Alliance. 2019;7(4):106–108. (In Russ.) doi: 10.36422/23076348201974106108
- Iurev VK, Zhirkov PG. The prevalence of some lifestyle risk factors, negatively affecting the health of high school students. Pediatrician (St. Petersburg). 2018;9(2): 49–54. (In Russ.) doi: 10.17816/PED9249-54
- Yablonskiy PK, Sukhovskaya OA. Effect passive exposure electronic nicotine delivery system on health. Medical Alliance. 2019;7(2):99–104. (In Russ.)
- Yablonskiy PK, Sukhovskaya OA. Electronic cigarettes — “way of smoking” or quit smoking devices? Commentary article on VD Mendelevich. The Bulletin of Contemporary Clinical Medicine. 2015;8(3):72–74. (In Russ.) doi: 10.20969/VSKM.2015.8(3).72-74
- Yablonskiy PK, Sukhovskaya OA, Smirnova MA. Influence of tobacco smoking on COVID-19 incidence and outcome. Medical Alliance. 2020;8(2):93–97. (In Russ.) doi: 10.36422/23076348-2020-8-2-93-97
- Yablonskiy PK, Sukhovskaya OA, Smirnova MA, Vasil’ev VS. Change in smoking behaviour during COVID-19 pandemic. Medical Alliance. 2021;9(3):89–95. (In Russ.) doi: 10.36422/23076348-2021-9-3-89-95
- Crotty Alexander LE, Bellinghausen AL, Eakin MN. What are the mechanisms underlying vaping-induced lung injury? J Clin Invest. 2020;130(6):2754–2756. doi: 10.1172/JCI138644.
- Crotty Alexander LE, Perez MF. Identifying, tracking, and treating lung injury associated with e-cigarettes or vaping. Lancet. 2019;394(10214):2041–2043. doi: 10.1016/S0140-6736(19)32730-8
- Corey CG, Ambrose BK, Apelberg BJ, King BA. Flavored tobacco use among middle and high school students — United States, 2011–2014. Morb Mortal Wkly Rep. 2015;64(38):1066–1077. doi: 10.15585/mmwr.mm6438a2
- Basset-Léobon C, Lacoste-Collin L, Bes AJC, Courtade-Saidi M. Cut-off values and significance of oil red O-positive cells in bronchoalveolar lavage fluid. Cytopathology. 2010;21(4):245–250. doi: 10.1111/j.1365-2303.2009.00677.x
- Beasley MB. The pathologist’s approach to acute lung injury. Arch Pathol Lab Med. 2010;134(5):719–727. doi: 10.5858/134.5.719
- Bhat TA, Kalathil SG, Bogner PN, et al. An animal model of inhaled vitamin e acetate and EVALI-like lung injury. N Engl J Med. 2020;382(12):1175–1177. doi: 10.1056/NEJMc2000231
- Blount BC, Karwowski MP, Shields PG, et al. Vitamin E acetate in bronchoalveolar-lavage fluid associated with EVALI. N Engl J Med. 2020;382(8):697–705. doi: 10.1056/NEJMoa1916433
- Bozier J, Chivers EK, Chapman DG, et al. The evolving landscape of e-cigarettes: A systematic review of recent evidence. Chest. 2020;157(5):1362–1390. doi: 10.1016/j.chest.2019.12.042
- Butt YM, Smith ML, Tazelaar HD, et al. Pathology of vaping-associated lung injury. N Engl J Med. 2019;381(18): 1780–1781. doi: 10.1056/NEJMc1913069
- Callahan SJ, Harris D, Collingridge DS, et al. Diagnosing EVALI in the time of COVID-19. Chest. 2020;158(5): 2034–2037. doi: 10.1016/j.chest.2020.06.029
- Carroll BJ, Kim M, Hemyari A, et al. Impaired lung function following e-cigarette or vaping product use associated lung injury in the first cohort of hospitalized adolescents. Pediatr Pulmonol. 2020;55(7): 1712–1718. doi: 10.1002/ppul.24787
- Cecchini MJ, Mukhopadhyay S, Arrossi AV, et al. E-Cigarette or vaping product use-associated lung injury: A review for pathologists. Arch Pathol Lab Med. 2020;144(12): 1490–1500. doi: 10.5858/arpa.2020-0024-RA
- www.cdc.gov [Internet]. CDC updates EVALI guidance for health care providers as flu activity increases nationally [cited 2020 Aug 19]. Available at: https://www.cdc.gov/media/releases/2019/p1119-evali-guidance
- www.cdc.gov [Internet]. Centers for Disease Control and Prevention (CDC). Outbreak of lung injury associated with the use of e-cigarette, or vaping, products [cited 2020 Aug 19]. Available at: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html#latest-information
- Chaffee BW, Watkins SL, Glantz SA. Electronic cigarette use and progression from experimentation to established smoking. Pediatrics. 2018;141(4): e20173594. doi: 10.1542/peds.2017-3594
- Chan GCK, Gartner C, Lim C, et al. Association between the implementation of tobacco control policies and adolescent vaping in 44 lower-middle, upper-middle, and high-income countries. Addiction. 2022;117(8):2296–2305. doi: 10.1111/add.15892
- Chatham-Stephens K, Roguski K, Jang Y, et al. Characteristics of hospitalized and nonhospitalized patients in a nationwide outbreak of e-cigarette, or vaping, product use-associated lung injury — United States, November 2019. Morb Mortal Wkly Rep. 2019;68(46): 1076–1080. doi: 10.15585/mmwr.mm6846e1
- Corcoran A, Carl JC, Rezaee F. The importance of anti-vaping vigilance-EVALI in seven adolescent pediatric patients in Northeast Ohio. Pediatr Pulmonol. 2020;55(7):1719–1724. doi: 10.1002/ppul.24872
- Corwin RW, Irwin RS. The lipid-laden alveolar macrophage as a marker of aspiration in parenchymal lung disease. Am Rev Respir Dis. 1985;132(3):576–581. doi: 10.1164/arrd.1985.132.3.576
- Crotty Alexander LE, Vyas A, Schraufnagel DE, Malhotra A. Electronic cigarettes: the new face of nicotine delivery and addiction. J Thorac Dis. 2015;7(8):E248–E251. doi: 10.3978/j.issn.2072-1439.2015.07.37
- Crotty Alexander LE, Ware LB, Calfee CS, et al. E-cigarette or vaping product use-associated lung injury: Developing a research agenda. An NIH workshop report. Am J Respir Crit Care Med. 2020;202(6): 795–802. doi: 10.1164/rccm.201912-2332WS
- Czoli CD, Luongo G, Mischki T. Prevalence trends and factors associated with vaping in Ontario (2015 to 2018) and Quebec (2017 to 2019). Canada. Health Rep. 2022;33(7):13–23. doi: 10.25318/82-003-x202200700002-eng
- Davidson K, Brancato A, Heetderks P, et al. Outbreak of electronic-cigarette-associated acute lipoid pneumonia — North Carolina, July-August 2019. Morb Mortal Wkly Rep. 2019;68(36):784–786. doi: 10.15585/mmwr.mm6836e1
- Desai SR, Wells AU, Rubens MB, et al. Acute respiratory distress syndrome: CT abnormalities at long-term follow-up. Radiology. 1999;210(1):29–35. doi: 10.1148/radiology.210.1.r99ja2629
- www.leafly.com [Internet]. Downs D. Vape cart additive makers pull products as others go dark. 2019 [cited 2020 Jul 10]. Available at: https://www.leafly.com/news/health/some-vape-cart-additive-makers-pull-products-others-go-dark
- El Culbreth R, Brandenberger KJ, Battey-Muse CM, Gardenhire DS. 2021 year in review: E-cigarettes, hookah use, and vaping lung injuries during the COVID-19 pandemic. Respir Care. 2022;67(6): 709–714. doi: 10.4187/respcare.09919
- Fels Elliott DR, Shah R, Hess CA, et al. Giant cell interstitial pneumonia secondary to cobalt exposure from e-cigarette use. Eur Respir J. 2019;54(60):1901922. doi: 10.1183/13993003.01922-2019
- Henry TS, Kligerman SJ, Raptis CA, et al. Imaging findings of vaping-associated lung injury. Am J Roentgenol. 2020;214(3):498–505. doi: 10.2214/AJR.19.22251
- Henry TS, Kanne JP, Kligerman SJ. Imaging of vaping-associated lung disease. N Engl J Med. 2019;381(15): 1486–1487. doi: 10.1056/NEJMc1911995
- Huang J, Duan Z, Kwok J, et al. Vaping versus JUULing: how the extraordinary growth and marketing of JUUL transformed the US retail e-cigarette market. Tob Control. 2019;28(2):146–151. doi: 10.1136/tobaccocontrol-2018-054382
- Kale D, Perski O, Herbec A, et al. Changes in cigarette smoking and vaping in response to the COVID-19 pandemic in the UK: Findings from baseline and 12-month follow up of HEBECO study. Int J Environ Res Public Health. 2022;19(2):630. doi: 10.3390/ijerph19020630
- Kalininskiy A, Bach CT, Nacca NE, et al. E-cigarette, or vaping, product use associated lung injury (EVALI): case series and diagnostic approach. Lancet Respir Med. 2019;7(12):1017–1026. doi: 10.1016/S2213-2600(19)30415-1
- Kligerman S, Raptis C, Larsen B, et al. Radiologic, pathologic, clinical, and physiologic findings of electronic cigarette or vaping product use-associated lung injury (EVALI): Evolving knowledge and remaining questions. Radiology. 2020;294(3):491–505. doi: 10.1148/radiol.2020192585
- Layden JE, Ghinai I, Pray I, et al. Pulmonary Illness related to e-cigarette use in Illinois and Wisconsin — Final report. N Engl J Med. 2020;382(10):903–916. doi: 10.1056/NEJMoa1911614
- Leventhal AM, Goldenson NI, Cho J, et al. Flavored E-cigarette use and progression of vaping in adolescents. Pediatrics. 2019;144(5):e20190789. doi: 10.1542/peds.2019-0789
- Maddock SD, Cirulis MM, Callahan SJ, et al. Pulmonary lipid-laden macrophages and vaping. N Engl J Med. 2019;381(15):1488–1489. doi: 10.1056/NEJMc1912038
- Mukhopadhyay S, Mehrad M, Dammert P, et al. Lung biopsy findings in severe pulmonary illness associated with e-cigarette use (vaping). Am J Clin Pathol. 2020;153(1):30–39. doi: 10.1093/ajcp/aqz182
- Pambuccian SE. Testing for lipid-laden macrophages in bronchoalveolar lavage fluid to diagnose vaping-associated pulmonary injury. Are we there yet? J Am Soc Cytopathol. 2020;9(1):1–8. doi: 10.1016/j.jasc.2019.10.002
- Saqi A, Mukhopadhyay S, Butt Y, et al. E-cigarette or vaping product use-associated lung injury: What is the role of cytologic assessment? Cancer Cytopathol. 2020;128(6):371–380. doi: 10.1002/cncy.22237
- Sheard S, Rao P, Devaraj A. Imaging of acute respiratory distress syndrome. Respir Care. 2012;57(4):607–612. doi: 10.4187/respcare.01731
- Shin YM, Hunt DP, Akwe J. An epidemic supplanted by a pandemic: vaping-related illness and COVID-19. South Med J. 2022;115(1):8–12. doi: 10.14423/SMJ.0000000000001344
- Smith ML, Gotway MB, Crotty Alexander LE, Hariri LP. Vaping-related lung injury. Virchows Arch. 2021;478(1): 81–88. doi: 10.1007/s00428-020-02943-0
- Tehrani H, Rajabi A, Ghelichi-Ghojogh M, et al. The prevalence of electronic cigarettes vaping globally: a systematic review and meta-analysis. Arch Public Health. 2022;80(1):240. doi: 10.1186/s13690-022-00998-w
- Viswam D, Trotter S, Burge PS, Walters GI. Respiratory failure caused by lipoid pneumonia from vaping e-cigarettes. BMJ Case Rep. 2018;2018:bcr2018224350. doi: 10.1136/bcr-2018-224350
- Werner AK, Koumans EH, Chatham-Stephens K, et al. Hospitalizations and deaths associated with EVALI. N Engl J Med. 2020;382(17):589–1598. doi: 10.1056/NEJMoa1915314
- Whitaker M, Elliott J, Chadeau-Hyam M, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13(1):1957. doi: 10.1038/s41467-022-29521-z
- Winnicka L, Shenoy MA. EVALI and the pulmonary toxicity of electronic cigarettes: A review. J Gen Intern Med. 2020;35(7):2130–2135. doi: 10.1007/s11606-020-05813-2
- Wu D, O’Shea DF. Potential for release of pulmonary toxic ketene from vaping pyrolysis of vitamin E acetate. PNAS USA. 2020;117(12):6349–6355. doi: 10.1073/pnas.1920925117
- Rehan HS, Maini J, Hungin APS. Vaping versus smoking: A quest for efficacy and safety of e-cigarette. Curr Drug Saf. 2018;13(2):92–101. doi: 10.2174/1574886313666180227110556